Patent application number | Description | Published |
20120093771 | METHOD FOR PREPARING A HARDENED CALCIUM SULFATE DIHYDRATE BLOCK AND USE THEREOF - The present invention provides a technique for prolonging the working time and setting time of a calcium sulfate hemihydrate paste by mixing calcium sulfate hemihydrate powder with an aqueous solution containing phosphate ions, so that the paste is suitable for operation and the resultant hardened calcium sulfate dihydrate block from the paste has an improved mechanical strength. | 04-19-2012 |
20120095518 | BONE CEMENT FORMULA AND BIORESORBABLE HARDENED BONE CEMENT COMPOSITES PREPARED WITH THE SAME - The present invention provides a bone cement formula having a powder component and a setting liquid component, wherein the powder component includes a calcium sulfate source and a calcium phosphate source with a weight ratio of the calcium sulfate source less than 65%, based on the total weight of the calcium sulfate source and the calcium phosphate source, and the setting liquid component comprises ammonium ion (NH | 04-19-2012 |
20130138114 | CALCIUM-BASED BONE CEMENT FORMULA WITH ENHANCED NON-DISPERSIVE ABILITY - A calcium-based bone cement formula having a powder component and a setting liquid component with a liquid to powder ratio of 0.20 ml/g to 0.50 ml/g is provided, wherein the powder component includes tetracalcium phosphate. The bone cement formula further contains, based on the total weight of the bone cement formula, 0.01-1% of poly(acrylic acid) having a repeating unit of —(CH | 05-30-2013 |
20130139564 | Method for increasing mechanical strength of titanium alloys having alpha" phase by cold working - A process for making an article of a titanium alloy having α″ phase as a major phase according to the present invention includes providing a work piece of a titanium alloy consisting essentially of 7-9 wt % of molybdenum and the balance titanium and having α″ phase as a major phase; and cold working at least a portion of the work piece at room temperature to obtain a green body of the article, wherein the cold worked portion of the green body has a thickness which is 20%-80% of that of the at least a portion of the work piece, and the cold worked portion has α″ phase as a major phase. | 06-06-2013 |
20130139933 | Method for enhancing mechanical strength of a titanium alloy by aging - A titanium-molybdenum alloy having α″ phase as a major phase is subjected to an aging treatment, so that yield strength of the aged alloy is increased by 10% to 120% with elongation to failure thereof being not less than about 5.0%. | 06-06-2013 |
20140081280 | METHOD AND APPARATUS FOR DELIVERING CEMENT PASTE INTO A BONE CAVITY - The present invention is related to a technique for simultaneously forming a plurality of paste filled tunnels. The plurality of paste filled tunnels are connected to a surgical tube directly or indirectly and emptied one after another, until a desired amount of the paste is injected into a bone cavity, organ or a tissue via the surgical tube. The paste may be a bone cement paste, a drug powder paste, viscous fluid or gel. The injected bone cement paste will set in the bone cavity to act as a medical implant. | 03-20-2014 |
20140148814 | METHOD AND APPARATUS FOR DELIVERING CEMENT PASTE INTO A BONE CAVITY - The present invention is related to a technique for simultaneously forming a plurality of paste filled tunnels. The plurality of paste filled tunnels are connected to a surgical tube directly or indirectly and emptied one after another, until a desired amount of the paste is injected into a bone cavity, organ or a tissue via the surgical tube. The paste may be a bone cement paste, a drug powder paste, viscous fluid or gel. The injected bone cement paste will set in the bone cavity to act as a medical implant. | 05-29-2014 |
20150272647 | METHOD AND APPARATUS FOR DELIVERING CEMENT PASTE INTO A BONE CAVITY - A technique for simultaneously forming a plurality of paste filled tunnels. The plurality of paste filled tunnels are connected to a surgical tube directly or indirectly and emptied one after another, until a desired amount of the paste is injected into a bone cavity, organ or a tissue via the surgical tube. The paste may be a bone cement paste, a drug powder paste, viscous fluid or gel. The injected bone cement paste will set in the bone cavity to act as a medical implant. | 10-01-2015 |
Patent application number | Description | Published |
20080300447 | Dual-Pulsation Bi-Ventricular Assist Device - A ventricular assist device is disclosed which comprises a sac for wrapping around a portion of a heart, the sac having one or more inflatable chambers for compressing the heart when the chambers being inflated and a blood outlet made to an aorta, the blood outlet being the sole opening in the human blood path in the vicinity of heart, wherein during a systolic phase the inflatable chambers inflate while blood flows out of the aorta through the blood outlet, and during a diastolic phase the inflatable chambers deflate while blood flows into the aorta through the blood outlet. | 12-04-2008 |
20080306329 | Ventricular Assist Device - A manifold for accessing blood from a human blood vessel is disclosed which comprises a first and a second pathway intersecting with each other at an angle, the first pathway being configured to be completed embedded in the human blood vessel with the second pathway leading toward outside of the human blood vessel wherein the manifold is substantially retained by the human blood vessel alone. | 12-11-2008 |
20100076480 | Orthopaedic paste delivering tool and method for continually delivering the paste, and devices and methods for facilitating the delivery of the orthopaedic paste - The present invention discloses a technique for continually delivering an orthopaedic paste into a bone, which will harden in the bone and act as a medical implant. The present invention uses a replacement mechanism in delivering the paste stored in a chamber through a tube in fluid communication with the chamber, which includes invading the paste in the chamber with a small volume of recovery member such as a rod to replace the same volume of paste into the tube, and retreating the invading rod while applying a pressure to the paste in the chamber, so that a space created by the retreating is replaced by the paste, and repeating the invasion and the retreating alternately to continually deliver the paste through the tube. | 03-25-2010 |
20110093025 | BONE CAVITY CREATION AND METHOD WITH MAGNETIC FORCE RETRIEVABLE BEADS - The present invention discloses a method of using beads to create a cavity in a bone, which includes introducing beads into a bone by applying a pressure on said beads, wherein the beads are metallic beads able to be attracted by a magnet; and withdrawing the beads from the bone by magnetic force. Preferably, a pocket is disposed in the bone prior to the introduction of beads, and the introduction and withdraw of the beads are carried out with respect to said pocket. | 04-21-2011 |
20120277754 | METHOD AND APPARATUS FOR DELIVERING CEMENT PASTE INTO A BONE CAVITY - The present invention is related to a technique for simultaneously forming a plurality of paste filled tunnels. The plurality of paste filled tunnels are connected to a surgical tube directly or indirectly and emptied one after another, until a desired amount of the paste is injected into a bone cavity, organ or a tissue via the surgical tube. The paste may be a bone cement paste, a drug powder paste, viscous fluid or gel. The injected bone cement paste will set in the bone cavity to act as a medical implant. | 11-01-2012 |
20120330365 | In-Situ Deformable Mini-Bone Plate - A bone plate provided in the present invention has an elongated strip, and a series of repeating units are provided on the elongated strip. Each repeating unit has two crowns, two necks, and four bridges, wherein the two crowns and the two necks are connected by the four bridges to from a symmetrical ring structure, and wherein a width of the bridge (BW) is greater than a width of the crown (CW), a maximum distance between inner sides of the two crowns (ID) is greater than a width of the neck (NW), a maximum distance between outer sides of two opposite bridges of the four bridges (OD) is greater than a unit length between two adjacent repeating units (UL), and the crown width (CW) is | 12-27-2012 |
20130284737 | Graphite foil-bonded device and method for preparing same - A device has a layered structure, and the layered structure has a graphite foil bonded to a surface of a substrate, wherein the graphite foil contains a laminate of a plurality of natural graphite flakes parallel to the surface of the substrate, wherein the graphite foil and the surface of the substrate are bonded through diffusion bonding directly, or bonded with a cured resin, a cured pitch, a carbonized resin, a carbonized pitch, a graphitized resin or a graphitized pitch in between, wherein the graphite foil contains not less than 95%, preferably 99%, of carbon. | 10-31-2013 |
20130295193 | Antibacterial calcium-based materials - A preparation at least useful as a bone implant is provided, which contains a solid component including a lithium compound and a calcium compound. The preparation shows an anti-bacterial ability in comparison with a preparation contains the calcium compound but free of the lithium compound. | 11-07-2013 |
20150111178 | Dental Implant with Cushion - An dental implant has a substantially cylindrical hollow base member; an abutment; an implant-abutment junction (IAJ) portion at one end of the base member to retain the abutment to the base member, so that the abutment is able to move within a predetermined distance alone an axial direction of the base member, and a first cushion adapted to be mounted between the abutment and the base member for providing a resistance force when the abutment is pressed to move relatively toward the base member and providing a bouncing back force when the abutment is released from the pressing. | 04-23-2015 |
Patent application number | Description | Published |
20130004473 | Methods and Biomarkers for the Detection of Dengue Hemorrhagic Fever - The present invention provides methods for detecting, analyzing, and identifying biomolecules used to identifying patient with dengue-like symptom who are at risk of DHF. The inventive method comprises detecting in a sample from a subject dengue infected patient one or more biomarkers selected from the group consisting of IL-10, fibrinogen, C4A, immunoglobulin, tropomyosin, and three isoforms of albumin, and which are used in a predictive MARS model to detect patients with risk of developing DHF. | 01-03-2013 |
20150316562 | METHOD AND BIOMARKERS FOR THE DETECTION OF DENGUE HEMORRHAGIC FEVER - The present invention provides methods for detecting, analyzing, and identifying biomolecules used to identifying patient with dengue-like symptom who are at risk of DHF. The inventive method comprises detecting in a sample from a subject dengue infected patient one or more biomarkers selected from the group consisting of IL-10, fibrinogen, C4A, immunoglobulin, tropomyosin, and three isoforms of albumin, and which are used in a predictive MARS model to detect patients with risk of developing DHF. | 11-05-2015 |
20150377911 | BIOMARKERS FOR CHAGAS DISEASE RELATED CARDIOMYOPATHY - Certain embodiments include methods for assessing a subject having a trypanosome infection for the presence or absence of indications of cardiomyopathy. | 12-31-2015 |
20160003845 | Method and Biomarkers for the Detection of Dengue Hemorrhagic Fever - The present invention provides compositions and methods for detecting, analyzing, and identifying biomolecules used to diagnose patient with risk of DHF. More particularly, the invention provides plasma biomarkers including complement factor D to complement factor H (FactorD/FactorH) ratio and levels of one or more of IL2, desmoplakin, and high molecular weight albumin, which are used to detect risk of developing DHF. | 01-07-2016 |
Patent application number | Description | Published |
20110166201 | MIRNAS AS THERAPEUTIC TARGETS IN CANCER - MicroRNAs (miRNAs) are a class of non-coding small RNA molecules that regulate gene expression at the post-transcriptional level by interacting with 3′ untranslated regions (UTRs) of their target mRNAs. The invention relates to the application of miR-192 and miR-215. Both of these miRNAs impact cellular proliferation through the p53-miRNA circuit, and interact with dihydrofolate reductase (DHFR) and thymidylate synthase (TS). Particularly, upregulation of these miRNAs reduces cellular proliferation. The invention relates to this discovery. For example, inhibiting miR-192 and/or miR-215 sensitizes a neoplasm or a subject with a neoplasm to chemotherapeutic agents. Furthermore, measuring the levels of miR-192 and/or miR-215 provides one with information regarding whether the neoplasm or subject will respond to chemotherapeutic agents. Accordingly, the invention relates to composition and methods relating to the identification, characterization and modulation of the expression of miR-192 and miR-215. | 07-07-2011 |
20120087992 | miRNAS AS THERAPEUTIC TARGETS IN CANCER - Methods for modulating expression of a component of a cell, comprising contacting the cell with a nucleic acid comprising an miR-140 nucleic acid sequence in an amount sufficient to modulate the cellular component are provided. Overexpression of miR-140 inhibits cell proliferation in both U-2 OS (wt-p53) and HCT 116 (wt-p53) cell lines. Cells transfected with miR-140 are more resistant to chemotherapeutic agent methotrexate, mi-140 expression is related to HDAC4 protein expression. The claimed methods reduce the protein expression level of HDAC4 without degrading the target mRNA. | 04-12-2012 |
20150152422 | MIRNAS AS THERAPEUTIC TARGETS IN CANCER - MicroRNAs (miRNAs) are a class of non-coding small RNA molecules that regulate gene expression at the post-transcriptional level by interacting with 3′ untranslated regions (UTRs) of their target mRNAs. The invention relates to the application of miR-192 and miR-215. Both of these miRNAs impact cellular proliferation through the p53-miRNA circuit, and interact with dihydrofolate reductase (DHFR) and thymidylate synthase (TS). Particularly, upregulation of these miRNAs reduces cellular proliferation. The invention relates to this discovery. For example, inhibiting miR-192 and/or miR-215 sensitizes a neoplasm or a subject with a neoplasm to chemotherapeutic agents. Furthermore, measuring the levels of miR-192 and/or miR-215 provides one with information regarding whether the neoplasm or subject will respond to chemotherapeutic agents. Accordingly, the invention relates to composition and methods relating to the identification, characterization and modulation of the expression of miR-192 and miR-215. | 06-04-2015 |
20160024597 | miRNAs AS THERAPEUTIC TARGETS IN CANCER - Methods for modulating expression of a component of a cell, comprising contacting the cell with a nucleic acid comprising an miR-140 nucleic acid sequence in an amount sufficient to modulate the cellular component are provided. Overexpression of miR-140 inhibits cell proliferation in both U-2 OS (wt-p53) and HCT 116 (wt-p53) cell lines. Cells transfected with miR-140 are more resistant to chemotherapeutic agent methotrexate. mi-140 expression is related to HDAC4 protein expression. The claimed methods reduce the protein expression level of HDAC4 without degrading the target mRNA. | 01-28-2016 |
20160090636 | MicroRNA-129 AS A BIOMARKER FOR COLORECTAL CANCER - The current disclosure describes methods for identifying subjects that would benefit from treatment with a chemotherapeutic agent. The disclosure is based in part on the observation that miR-129 expression levels are reduced in colorectal cancer. Accordingly, the current disclosure provides therapeutic compositions and methods for altering the expression of a miR-129 effector. Described herein are methods for characterizing the stage of colorectal cancer in a subject, based on the levels of miR-129 expression. The disclosure also identifies miR-129 as a predictive biomarker for cancer diagnosis and the subsequent treatment with directed therapeutic agents including but not limited to miR-129 nucleic acid molecules and/or a chemotherapeutic agent. The current disclosure also identifies novel therapeutic agents that modulate the level of BCL2, TS and/or E2F3 expression, as well as sensitize a subject to treatment with a chemotherapeutic agent. | 03-31-2016 |
Patent application number | Description | Published |
20080241885 | PROCESS FOR PRODUCING CELLULASE - Various methods for the production of cellulase are disclosed. In one embodiment the method for producing cellulase includes contacting a culture comprising a sophorolipid producer and a cellulase producer with a substrate that is consumed by the sophorolipid producer. In addition, a microorganism culture made from a sophorolipid producer and a cellulase producer is disclosed. | 10-02-2008 |
20090008325 | Affinity Foam Fractionation for Collection and Purification of Materials - The present invention generally relates to methods for purifying and/or concentrating compounds from or in solutions and/or mixtures. In one embodiment, the present invention relates to a method for purifying and/or concentrating a compound from a solution or mixture. In another embodiment, the present invention relates to a method for purifying/concentrating a compound from a solution or mixture that utilizes, in whole or part, foam purification and/or concentration. In still another embodiment, the present invention can be used to separate, concentrate and/or purify any material, including biological products and/or biomaterials, that can be selectively bound to a binding agent, thereby yielding a complex that will readily partition onto bubble surfaces in a foam. | 01-08-2009 |
20100297714 | Multi-Step Method for Producing Algae Products - A multi-step method for producing an algae product comprising, a microorganism consumption step, another step, and an algae product collection step. The microorganism consumption step comprises, combining a liquid growth medium comprising microorganisms with a phagotrophic algae capable of producing a desired algae product, consuming said microorganisms by said phagotrophic algae, and growing said phagotrophic algae. Another step comprises either a microorganism growth step or a photosynthetic algal growth step. A microorganism growth step comprises providing a liquid growth medium comprising nutrients and microorganisms capable of said consuming said nutrients, consuming said nutrients by said microorganisms, and growing said microorganisms. A photosynthetic algal growth step comprises providing a substantially organic nutrient depleted liquid medium, providing a microorganism population comprising said phagotrophic algae, photosynthetic growth of said phagotrophic algae. An algae product collection step comprises collecting a desired algae product from said phagotrophic algae. | 11-25-2010 |
20110027858 | Method of Modifying Fungal Morphology - Provided is a method of modifying fungal morphology. The method comprises introducing an amount of a surfactant to a fungus, or to a growing mixture comprising a fungus, wherein said amount of a surfactant is sufficient to induce a change in the morphology of said fungus. | 02-03-2011 |
20130116475 | PRODUCTION OF ARABITAL - A method for producing arabitol, and more particularly to producing arabitol in a major amount based on a total weight of all polyols produced and in relatively high concentration from a mixture including a carbon source such as glycerol. The method includes in one embodiment utilizing select yeast strains to produce arabitol in high yield while minimizing the amounts of other polyols, using carbon sources such as glycerol as a component in a medium. In a beneficial embodiment, biodiesel byproduct glycerol is used as the substrate for arabitol production. | 05-09-2013 |
20140038247 | ALGAE HAVING INTRACELLULAR LIPID PARTICLES AND HIGH LIPID CONTENT - A method for increasing the lipid content of algae includes combining algae and a lipid-precipitating addition in a growth-inhibitive medium, the growth-inhibitive medium being deficient in at least one nutrient that is necessary for reproductive growth of algae, thus frustrating algae reproduction, the lipid-precipitating addition selected from hydroxyl-containing compounds and amine-containing compounds. An organic acid addition may also be combined with the lipid-precipitating addition and algae in the growth-inhibitive medium, the organic acid addition including compounds containing carboxylic acid functionality. Direct production of biodiesel is also achieved by the use of particular lipid-precipitating additions and organic acid additions. | 02-06-2014 |
20140113138 | METHOD OF ENCAPSULATION AND IMMOBILIZATION - A method for encapsulating a material comprises the steps of choosing a material to encapsulate; placing the material into a material solvent to form a material solution; forming a primary emulsion of the material solution in an immiscible liquid medium that is immiscible with the material solvent, the material solution serving as the disperse phase and the immiscible liquid medium serving as the continuous phase of the primary emulsion, wherein the immiscible liquid medium contains an encapsulating agent dissolved therein, the encapsulating agent being capable of being crosslinked, polymerized, gelled or otherwise hardened or solidified; adding the primary emulsion as droplets into a crosslinking medium, and thereafter activating the crosslinking, polymerizing, gelling, hardening or solidifying of the encapsulating agent to envelope the material in a crosslinked, polymerized, gelled or otherwise hardened or solidified matrix forming the droplets into beads. | 04-24-2014 |
20140364381 | WOUND DRESSINGS WITH ENHANCED GAS PERMEATION AND OTHER BENEFICIAL PROPERTIES - A wound dressing comprises a wound dressing substrate including one or more of gas vesicles, rhamnolipids, and sophorolipids. The wound dressing can be fabric-based or hydrogel-based. Methods for producing a wound dressing are also provided. | 12-11-2014 |
20150037852 | METHOD AND SYSTEM FOR REDUCING FREE FATTY ACID CONTENT OF A FEEDSTOCK - A method for reducing the free fatty acid content of a feedstock includes the steps of providing a free-fatty-acid-containing feedstock, treating the free-fatty-acid-containing feedstock to reduce the free fatty acid content thereof, where the step of treating includes combining at least one of an algae and a coagulant to the free-fatty-acid-containing feedstock, and producing a product from the treated feedstock. | 02-05-2015 |
20150118730 | ENZYME-BASED PROTEIN SEPARATION AND ENRICHMENT FROM SOY MEAL, WHEAT MEAL, AND OTHER PROTEIN-RICH MATERIALS DERIVED FROM PLANT SEEDS, FRUITS AND OTHER BIOMASS - The present invention is directed to enzyme based methods for separating protein from protein-rich materials derived from plant seeds, fruit, or other biomass and products made therefrom. The protein content in the resulting products is improved by separating and removing the carbohydrates from around the proteins in, for example, soybean meal. This removal is facilitated by the enzymatic hydrolysis of poly- and oligomeric carbohydrates into monosaccharides and other water soluble sugars. The present invention provides for the production of three streams of useful materials. The first is an enriched protein material comparable to the known SPCs but without significant quantities of undigestible oligosaccharides and polysaccharides. The second is an SPI made from the soluble protein in the hydrolysate which is valuable for high-quality feed, food and industrial uses. The third is the soluble saccharides and hydrolyzed carbohydrates (releasing sugars) that can be converted by fermentation to various valuable bioproducts. | 04-30-2015 |
20150336066 | METHOD OF ENCAPSULATION AND IMMOBILIZATION - A method for encapsulating a material, the steps include choosing a material to encapsulate; placing the material into a material solvent to form a material solution; forming a primary emulsion of the material solution in an immiscible liquid medium that is immiscible with the material solvent, wherein the material solution is the disperse phase and the immiscible liquid medium is the continuous phase of the primary emulsion, wherein the immiscible liquid medium contains an encapsulating agent dissolved therein, the encapsulating agent capable of being crosslinked, polymerized, gelled, hardened or solidified; adding the primary emulsion as droplets into a crosslinking medium, wherein the crosslinking medium is immiscible with the continuous phase immiscible liquid medium of the primary emulsion, and thereafter activating the crosslinking, polymerizing, gelling, hardening or solidifying of the encapsulating agent to envelope the material in a crosslinked, polymerized, gelled, hardened or solidified matrix forming the droplets into beads. | 11-26-2015 |
20160090317 | Digestion of Waste Activated Sludge with Algae - Phagotrophic algae are used in connection with aerobic or anaerobic digestion of solids, especially waste activated sludge (WAS), to more efficiently digest solids and to meet, over a shorter period of time, volatile solids standards and specific oxygen uptake rate requirements as well as pathogen reduction requirements. | 03-31-2016 |
20160102007 | PRODUCING ALGAL BIOMASS AND PRODUCTS FROM ORGANIC SOLID MATERIAL - A method for treating solid organic materials includes providing phagotrophic algae, providing solid organic material, combining the algae and the solid organic material, allowing the algae to grow by engulfing or uptaking the solid organic material, forming an algal product, and collecting the algal product. The method can also include a pretreatment step. The solid organic material can be waste activated sludge. A system for treating and disposing solid organic material is also provided. | 04-14-2016 |
Patent application number | Description | Published |
20100310607 | PHARMACEUTICAL FORMULATIONS - The present invention relates to oral formulations comprising an active agent comprising at least one of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid, salts of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid or buffered 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid. | 12-09-2010 |
20110136915 | RAPID DISSOLUTION FORMULATION OF A CALCIUM RECEPTOR-ACTIVE COMPOUND - The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a calcium receptor-active compound and at least one pharmaceutically acceptable excipient, wherein the composition has a controlled dissolution profile. The present invention further relates to a method of manufacturing the pharmaceutical composition, as well as a method of treating a disease using the pharmaceutical composition. | 06-09-2011 |
20110237675 | PHARMACEUTICAL FORMULATIONS - The present invention provides a modified release formulation comprising an active agent in a hydrophilic polymer matrix wherein the active agent is a salt of fenofibric acid wherein the release rate of the formulation in an in vitro dissolution is substantially independent of the ionic strength of the dissolution media. | 09-29-2011 |
20120171262 | PHARMACEUTICAL FORMULATIONS - The present invention relates to oral formulations comprising an active agent comprising at least one of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid, salts of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid or buffered 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid. | 07-05-2012 |
20130078284 | PHARMACEUTICAL FORMULATIONS - The present invention relates to oral formulations comprising an active agent comprising at least one of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid, salts of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid or buffered 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid. | 03-28-2013 |
20130085181 | PHARMACEUTICAL FORMULATIONS - The present invention provides a modified release formulation comprising an active agent in a hydrophilic polymer matrix wherein the active agent is a salt of fenofibric acid wherein the release rate of the formulation in an in vitro dissolution is substantially independent of the ionic strength of the dissolution media. | 04-04-2013 |
Patent application number | Description | Published |
20100011595 | RAZOR BLADES - A razor blade having a substrate with a cutting edge being defined by a sharpened tip. The substrate has a thickness of between about 1.3 and 1.6 micrometers measured at a distance of four micrometers from the blade tip, a thickness of between about 2.2 and 2.7 micrometers measured at a distance of eight micrometers from the blade tip, a thickness of between about 3.8 and 4.9 micrometers measured at a distance of sixteen micrometers from the blade tip, a ratio of thickness measured at four micrometers from the blade tip to the thickness measured at eight micrometers from the blade tip of at least 0.55 and a ratio of thickness measured at four micrometers from the blade tip to the thickness measured at sixteen micrometers from the blade tip of at least 0.30. | 01-21-2010 |
20110313559 | Use Of Printed Circuit Board, Electronic Component, And Semi-Conductor Assembly Equipment For The Assembly Of Razors And Components Thereof - The invention discloses a novel application of standard printed circuit board (PCB) assembly modules, electronic assembly, and/or semiconductor assembly equipment for the assembly of consumer products, such as razor cartridges. In addition, nozzles of the pick/place component placement machine of the present invention may be desirably adapted to operate on type of razor cartridge component (e.g., blade, lubricating strip) disposed on a pallet. The adapted nozzle may include adaptors which may have an elongated portion, an angled portion, a tapered portion, a gripper portion, a curved portion, a rounded portion, a pointed tip, a stamper, a marker, a printer, a guide portion, a spring portion, a moveable leg, or any combination thereof, for operating on a razor cartridge component. | 12-22-2011 |
20130014396 | RAZOR BLADES HAVING A WIDE FACET ANGLE - A razor blade including a substrate with a coating joined to the substrate defining a coated blade. The coated blade including a cutting edge being defined by a blade tip having a tip radius of from 50 to 350 angstroms. The coated blade having a pair of first facets extending from the blade tip and a pair of second facets extending from the respective first facets, a facet angle from 90° to 135°, a facet width from 0.38 micrometers to 0.65 micrometers a wedge angle from 5° to 30°, and a thickness of between 0.8 and 1.5 micrometers measured at a distance of 1 micrometer from the blade tip. | 01-17-2013 |
20130031794 | RAZOR BLADES WITH ALUMINUM MAGNESIUM BORIDE (AlMgB14)-BASED COATINGS - This invention relates to a novel application of hard, low friction aluminum magnesium boride (AlMgB | 02-07-2013 |
20150328789 | RAZOR BLADES - A razor blade having a substrate with a cutting edge being defined by a sharpened tip. The substrate has thicknesses of 1.60-1.75 micrometers and 9.25-10.00 micrometers measured at a distance of four and forty micrometers from the blade tip, respectively. A ratio of the thickness measured at four micrometers to the thickness measured at forty micrometers is between 0.165-0.185. The substrate thickness is about 2.70-3.00 micrometers at eight micrometers from the blade tip, about 4.44-5.00 micrometers at sixteen micrometers from the blade tip with a thickness ratio measured at four micrometers and eight micrometers between 0.56-0.62, and a thickness ratio measured at four micrometers and sixteen micrometers between 0.32-0.40. The blade edge shape is defined by equation w=ad | 11-19-2015 |
20160089801 | USE OF PRINTED CIRCUIT BOARD, ELECTRONIC COMPONENT, AND SEMI-CONDUCTOR ASSEMBLY EQUIPMENT FOR THE ASSEMBLY OF RAZORS AND COMPONENTS THEREOF - The invention discloses a novel application of standard printed circuit board (PCB) assembly modules, electronic assembly, and/or semiconductor assembly equipment for the assembly of consumer products, such as razor cartridges. In addition, nozzles of the pick/place component placement machine of the present invention may be desirably adapted to operate on type of razor cartridge component (e.g., blade, lubricating strip) disposed on a pallet. The adapted nozzle may include adaptors which may have an elongated portion, an angled portion, a tapered portion, a gripper portion, a curved portion, a rounded portion, a pointed tip, a stamper, a marker, a printer, a guide portion, a spring portion, a moveable leg, or any combination thereof, for operating on a razor cartridge component. | 03-31-2016 |